• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response of segmental vitiligo to 0.05% clobetasol propionate cream.

作者信息

Khalid M, Mujtaba G

机构信息

Department of Dermatology, Nishtar Medical College, Multan, Pakistan.

出版信息

Int J Dermatol. 1998 Sep;37(9):705-8. doi: 10.1046/j.1365-4362.1998.00557.x.

DOI:10.1046/j.1365-4362.1998.00557.x
PMID:9762827
Abstract
摘要

相似文献

1
Response of segmental vitiligo to 0.05% clobetasol propionate cream.节段性白癜风对0.05%丙酸氯倍他索乳膏的反应。
Int J Dermatol. 1998 Sep;37(9):705-8. doi: 10.1046/j.1365-4362.1998.00557.x.
2
Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo.
Int J Dermatol. 1995 Mar;34(3):203-5. doi: 10.1111/j.1365-4362.1995.tb01570.x.
3
Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.丙酸氯倍他索洗剂治疗中度至重度斑块型银屑病。
Cutis. 2004 Sep;74(3):201-6.
4
A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.一项比较0.1%他克莫司与0.05%丙酸氯倍他索治疗儿童白癜风的双盲随机试验。
Arch Dermatol. 2003 May;139(5):581-5. doi: 10.1001/archderm.139.5.581.
5
0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.0.25%的丙缩羟强的松龙乳膏及其相应的赋形剂比0.1%的倍他米松-17-戊酸酯乳膏和0.05%的丙酸氯倍他索乳膏引起的皮肤萎缩更少。
Eur J Clin Pharmacol. 1992;42(2):159-61. doi: 10.1007/BF00278477.
6
Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.外用0.05%丙酸氯倍他索与1%吡美莫司软膏治疗白癜风的对比研究
Eur J Dermatol. 2005 Mar-Apr;15(2):88-91.
7
Calcipotriol ointment versus clobetasol ointment in localized vitiligo: an open, comparative clinical trial.卡泊三醇软膏与丙酸氯倍他索软膏治疗局限性白癜风的开放、对照临床试验
Int J Dermatol. 2002 Sep;41(9):616-8. doi: 10.1046/j.1365-4362.2002.01486_3.x.
8
In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.与0.05%丙酸氯倍他索乳膏和泡沫以及赋形剂相比，对0.1%超强效外用皮质类固醇氟轻松乳膏的皮肤萎缩潜力进行体内测定。
J Drugs Dermatol. 2008 Jan;7(1):28-32.
9
Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.口服及外用L-苯丙氨酸、丙酸氯倍他索和紫外线A/阳光——一项治疗白癜风的新研究。
J Drugs Dermatol. 2002 Sep;1(2):127-31.
10
Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis.根据超声分析比较中效和强效外用糖皮质激素乳膏和软膏的致萎缩潜力。
Skin Pharmacol. 1992;5(2):77-80. doi: 10.1159/000211022.

引用本文的文献

1
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study.308纳米单色准分子光与外用0.1%他克莫司软膏联合治疗节段性白癜风的安全性和有效性：一项开放标签研究。
J Clin Aesthet Dermatol. 2020 Feb;13(2):E69-E75. Epub 2020 Feb 1.
2
A pilot study of 1% pimecrolimus cream for the treatment of childhood segmental vitiligo.1%吡美莫司乳膏治疗儿童节段性白癜风的一项试点研究。
Ann Dermatol. 2013 May;25(2):168-72. doi: 10.5021/ad.2013.25.2.168. Epub 2013 May 10.